Delivery Order SPE2DE24D0021-SPE2D625F8N9T
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $5,942.11 for Thermo Scientific DRI Fentanyl II drugs on November 14, 2025, with an ultimate completion date of November 20, 2025. This fixed-price contract with economic price adjustment was issued by the Department of Defense's Medical Supply Chain for delivery to Pittsburgh, Pennsylvania. The award carries no set-aside designation, indicating Fisher Scientific competed in an open procurement environment. As a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $6,225.00 on June 24, 2025, for Thermo Scientific DRI Fentanyl II drugs to support the Medical Supply Chain, a defense-focused federal agency. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is classified as a child contract and carries a completion date of July 1, 2025. No set-aside designation was used in this procurement, indicating open competition. The supplies...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $5,942.11 from the Department of Defense's Medical Supply Chain for Thermo Scientific DRI Fentanyl II drugs, with an ultimate completion date of November 21, 2025. This contract, awarded on November 14, 2025, operates under a fixed-price agreement with economic price adjustment provisions and carries no set-aside designation, indicating open competition. The award represents a child contract issued under a larger...
- This federal contract award, valued at $2,015.00, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Fisher Scientific Company L.L.C., a for-profit limited liability company and major supplier of scientific products, equipment, and services to federal agencies. The contract is for the delivery of DRI FENTANYL II CTL 2X2X10MLRX medical supplies and was issued under a Delivery Order contract type with a Fixed Price with Economic Price Adjustment pricing structure....
- Fisher Scientific Company L.L.C. was awarded a $6,595 delivery order on September 15, 2025, for the procurement of Cedia Heroin Met6am Assay reagent supplies in 65ml quantities. This fixed-price delivery order with economic price adjustment is set to be completed by September 22, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract was funded through the Defense Department's Medical Supply Chain division and represents an open competition award with no set-aside designation....
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,200 on August 4, 2025, by the Defense Medical Supply Chain to provide toxicology and drugs of abuse control reagents and supplies. This fixed-price contract with economic price adjustment carries an ultimate completion date of August 18, 2025, and will be performed in Pittsburgh, PA. The award represents a child contract under a larger vehicle structure and was made through open competition with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,198.16 by the Department of Defense's Medical Supply Chain for benzodiazepine toxicology reagents, with an ultimate completion date of November 20, 2025. The award, issued on November 13, 2025, utilizes a fixed-price contract with economic price adjustment provisions and carries no set-aside designation, indicating open competition. This delivery order is a child contract under a larger Blanket Purchase Agreement...
- Fisher Scientific Company L.L.C. received a delivery order award on July 31, 2025, from the Department of Defense's Medical Supply Chain for reagent toxicology CEDIA buprenorphine supplies, with a ceiling value of $8,323.12. This fixed-price delivery order with economic price adjustment provisions is structured as a child contract, indicating it derives from a larger parent agreement—specifically Fisher Scientific's Blanket Purchase Agreement with the Department of Veterans Affairs' Veterans...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,060.80 for toxicology reagents, specifically methadone metabolite testing supplies, with a completion date of December 9, 2025. This is a fixed-price delivery order with economic price adjustment provisions, issued under a competitive procurement with no set-aside designation. The order is being performed in Pittsburgh, Pennsylvania, and funded by the Defense Department's Medical Supply Chain organization, reflecting...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,821.12 by the Medical Supply Chain division of the Department of Defense, with an ultimate completion date of June 11, 2025. The contract, issued on June 6, 2025, is structured as a fixed-price delivery order with economic price adjustment provisions and involves the procurement of 4,568,468,875 units of approximately 99.9% pure acetyl Fisher chemistry in 4-liter glass bottles. The place of performance is located...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F8N9TDelivery Order
Fisher Scientific Company L.L.C. has been awarded a $6,225 delivery order contract for Thermo Scientific DRI Fentanyl II drugs, with an ultimate completion date of May 28, 2025. This fixed-price contract with economic price adjustment was awarded without set-aside designation on May 20, 2025 by the Medical Supply Chain, a defense-focused federal agency. The contract will be performed in Pittsburgh, Pennsylvania, and represents a child contract under a larger vehicle structure. Fisher Scientific, a major supplier of scientific products and laboratory equipment to federal agencies since its SAM.gov registration in 2001, brings extensive experience in supplying specialized testing and medical solutions across multiple government departments. This delivery order aligns with Fisher Scientific's established capabilities in providing toxicology and drugs of abuse testing supplies, particularly through its significant Blanket Purchase Agreement with the Department of Veterans Affairs' Veterans Integrated Service Network 1 (VISN 1), valued at $1.65 million. The fentanyl reagent procurement supports laboratory testing and quality assurance functions, consistent with the company's track record of supplying advanced scientific instruments and specialized testing reagents to federal healthcare and research institutions. The contract's fixed-price structure with economic price adjustment provides cost certainty while allowing for inflation adjustments over the delivery period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 5/20/25 |